This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Scripps Research Institute. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Taka-Aki Ichu: Innovator in Immunotherapy
Introduction
Taka-Aki Ichu is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of immunotherapy, particularly through her work on ABHD12 inhibitors. Her innovative approach aims to provide new treatments for cancer and infectious diseases.
Latest Patents
Taka-Aki Ichu holds a patent for "ABHD12 inhibitors and methods of making and using same." This patent includes compounds and compositions that serve as modulators of ABHD12. The subject compounds and compositions are particularly useful as immunotherapies, showcasing her commitment to advancing medical science.
Career Highlights
Ichu is affiliated with The Scripps Research Institute, where she conducts her research. Her work has garnered attention for its potential impact on treating serious health conditions. With 1 patent to her name, she continues to push the boundaries of innovation in her field.
Collaborations
Some of her notable coworkers include Daisuke Ogasawara and Jonathan Hulce. Their collaborative efforts contribute to the advancement of research and development in immunotherapy.
Conclusion
Taka-Aki Ichu exemplifies the spirit of innovation in the medical field. Her work on ABHD12 inhibitors represents a significant step forward in the fight against cancer and infectious diseases. Through her research at The Scripps Research Institute, she continues to inspire future advancements in immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile